Clinical Study on Acetyl-L-Carnitine

Inclusion Criteria: * Patients had signed the Informed Consent Form * Male or Female * Age 18-75 years old * Patients who have treated with Taxoids, Satraplatin and Vincristine; The peripheral sensory neuropathy grading after chemotherapy was \>/=grade 3 or grade 2 lasting for one month * The course of neuropathy was \</=6 months * No need to continue chemotherapy according to the condition nor refusing chemotherapy * At least one of the neuroelectrophysiological examine results were abnormal * Physical Condition Score (KPS) \>/=60 * Anticipated lifetime\>/=60. Exclusion Criteria: * Patients whose peripheral sensory neuropathy was induced by medicines except of the Taxoids, Satraplatin and vincristine anti-cancer chemotherapeutics * Diabetics * Peripheral sensory neuropathy was induced by Vitamin deficiency, infections, trauma, toxicosis, compression, and ischemia * Peripheral sensory neurologic dysfunction that induced by lesions of central nervous system; hereditary neuropathy * Patients who have treated by other medicines for peripheral sensory neuropathy in 30 days * Patients had treated by other clinical trial medicines or participated into other trials in 30 days * Patients had active infections * Any clinical problems out of control * Women in pregnancy and lactation, Subjects with no compliance.